MedTrace Logo

Mifepristone and Misoprostol for Mid-trimester Termination of Pregnancy in Ukraine

NCT02415894 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 172

Last updated 2016-07-22

No results posted yet for this study

Summary

The goal of this study is to examine the effectiveness and feasibility of a mifepristone-misoprostol medical abortion regimen in terminating pregnancies 13-22 weeks in Ukraine.

Conditions

  • Other Abortion

Sponsors & Collaborators

  • Gynuity Health Projects

    lead OTHER

Principal Investigators

  • Tamar Tsereteli, MD, PhD · Gynuity Health Projects

  • Galina Maistruk, MD · Woman Health and Family Planning Charitable Foundation

Eligibility

Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2015-04-30
Primary Completion
2016-04-30
Completion
2016-04-30

Countries

  • Ukraine

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02415894 on ClinicalTrials.gov